SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-301019
Filing Date
2022-12-08
Accepted
2022-12-08 16:04:13
Documents
19
Period of Report
2022-12-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d455790d8k.htm   iXBRL 8-K 31154
2 EX-99.1 d455790dex991.htm EX-99.1 18855
3 EX-99.2 d455790dex992.htm EX-99.2 16737
4 EX-99.3 d455790dex993.htm EX-99.3 10181
8 GRAPHIC g455790dsp111.jpg GRAPHIC 4446
9 GRAPHIC g455790g1205123243557.jpg GRAPHIC 2984
10 GRAPHIC g455790g1205123243870.jpg GRAPHIC 3892
11 GRAPHIC g455790g91c46.jpg GRAPHIC 11710
  Complete submission text file 0001193125-22-301019.txt   244519

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA meip-20221205.xsd EX-101.SCH 2856
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20221205_lab.xml EX-101.LAB 17994
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20221205_pre.xml EX-101.PRE 11265
13 EXTRACTED XBRL INSTANCE DOCUMENT d455790d8k_htm.xml XML 3342
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 221452399
SIC: 2834 Pharmaceutical Preparations